Peripheral Blood Stem Cells
Sponsors
Ribozyome, M.D. Anderson Cancer Center, Northwestern University, National Institute of Allergy and Infectious Diseases (NIAID), Masonic Cancer Center, University of Minnesota
Conditions
ALLAMLAcute Lymphocytic LeukemiaAcute Myelogenous LeukemiaB-Cell LymphomaBurkitt's LymphomaChronic Granulomatous Disease TransplantChronic Lymphocytic Leukemia
Phase 1
Phase 2
Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma
CompletedNCT00002221
Target: 5Updated: 2005-06-24
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
CompletedNCT01039025
Start: 2002-02-18End: 2006-05-19Updated: 2018-11-07
Allo HSCT Using RIC for Hematological Diseases
CompletedNCT02661035
Start: 2017-03-09End: 2023-05-29Updated: 2023-09-21
Haploidentical Donor vs mMUD in Hematological Malignancies
CompletedNCT03275636
Start: 2018-01-01End: 2024-04-13Updated: 2024-08-07
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
RecruitingNCT03520647
Start: 2019-02-19End: 2028-06-01Target: 56Updated: 2026-03-18